Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
source: pixabay.com

A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle

  It has been evident to scientists for years that Alzheimer’s disease, which affects about five million people in the U.S., is caused by an accumulation of two proteins within…

Continue Reading A New University of Alabama Study Finds That Norepinephrine is the Missing Piece in the Alzheimer’s Puzzle
New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
source: pixabay.com

New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future

According to a story from Newswise, a team of scientists and researchers associated with Université de Montréal and CHU Sainte-Justine have recently completed a study that maps a cellular model…

Continue Reading New Cellular Model of Chronic Granulomatous Disease Offers Hope for the Future
Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease
source: pixabay.com

Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease

  Falls are a symptom that affect about 60% of those with Parkinson's disease. This symptom can be debilitating, as many injuries can be the result. The University of Bristol…

Continue Reading Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease
New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
source: pixabay.com

New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome

According to a story from Gurufocus, the precision medicines company IDEAYA Biosciences, Inc. and the Boston Children's Hospital have recently entered into a Sponsored Research Agreement. The arrangement will entail…

Continue Reading New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
source: pixabay.com

The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy

According to an announcement from the Muscular Dystrophy Association, the organization has recently awarded a total of $1,076,232 in MDA Venture Philanthropy (MVP) funding towards the drug company AavantiBio, which…

Continue Reading The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
source: pixabay.com

Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation

Sickle Cell Disease  Sickle cell disease is a rare blood disorder. It is progressive, debilitating, and sadly can be life-threatening. The genetic defect leads patients' red blood cells to be…

Continue Reading Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
source: pixabay.com

A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden

According to a story from ALS News Today, the nation of Sweden is starting to emerge as a leader for amyotrophic lateral sclerosis (ALS) research in Europe. This is mostly…

Continue Reading A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden